Takeda Pharmaceutical Co Ltd
TAK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395064
In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 19 sales; 379 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; no superinvestor holds it.
Other share classesTKPHF
13F holders, Q2 2021
Institutional positions in Takeda Pharmaceutical Co Ltd as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 305
- −12 vs. Q1 2021
- Shares held
- 95.0M
- −12.9M (−11.9%) vs. Q1 2021
- Total value
- $1.60B
- −$363.8M (−18.5%) vs. Q1 2021
- New holders
- 29
- 93 more added
- Sold out
- 41
- 104 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TAK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 379 | $1.67B |
| Q1 2026 | 362 | $1.82B |
| Q4 2025 | 350 | $1.31B |
| Q3 2025 | 332 | $1.25B |
| Q2 2025 | 318 | $1.20B |
| Q1 2025 | 311 | $1.06B |
| Q4 2024 | 303 | $953.7M |
| Q3 2024 | 300 | $1.02B |
| Q2 2024 | 285 | $940.7M |
| Q1 2024 | 313 | $1.09B |
| Q4 2023 | 307 | $1.19B |
| Q3 2023 | 313 | $1.24B |
| Q2 2023 | 312 | $1.32B |
| Q1 2023 | 301 | $1.38B |
| Q4 2022 | 282 | $1.06B |
| Q3 2022 | 276 | $828.9M |
| Q2 2022 | 283 | $800.0M |
| Q1 2022 | 287 | $802.5M |
| Q4 2021 | 299 | $1.04B |
| Q3 2021 | 294 | $1.51B |
| Q2 2021 | 305 | $1.60B |
| Q1 2021 | 317 | $1.96B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Takeda Pharmaceutical Co Ltd; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 4,740,712 | $79.8M | 0.07% | +439,437+10.2% | Added |
| Price T Rowe Associates Inc | 5,386,303 | $90.7M | 0.01% | −50,595−0.9% | Reduced |
| Glenview Capital Management, LLC | 9,115,521 | $153.4M | 2.54% | −6,988,701−43.4% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 15,492,997 | $260.7M | 0.49% | −3,224,147−17.2% | Reduced |
| Blackcrane Capital, LLC | 21,469 | – | – | +6,898+47.3% | Added |
| Paulson & Co. Inc. | 0 | $0 | 0.00% | −4,727,415−100.0% | Sold out |
| BFAM Partners (Cayman) Ltd | 0 | $0 | 0.00% | −328,690−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −190,742−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −188,713−100.0% | Sold out |
| Twin Tree Management, LP | 0 | $0 | 0.00% | −167,007−100.0% | Sold out |
| Eagle Global Advisors LLC | 0 | $0 | 0.00% | −156,897−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −100,800−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −81,274−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −78,827−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −73,452−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −41,904−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −38,700−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −34,683−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −34,489−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −31,363−100.0% | Sold out |
| Baldwin Investment Management, LLC | 0 | $0 | 0.00% | −30,824−100.0% | Sold out |
| Quantitative Investment Management, LLC | 0 | $0 | 0.00% | −17,050−100.0% | Sold out |
| CAPROCK Group, Inc. | 0 | $0 | 0.00% | −16,656−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −12,377−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −10,737−100.0% | Sold out |
| Shelton Capital Management | 0 | $0 | 0.00% | −10,068−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −7,366−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −1,517−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −1,021−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −798−100.0% | Sold out |
| New England Asset Management Inc | 0 | $0 | 0.00% | −563−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −453−100.0% | Sold out |
| Mascoma Wealth Management LLC | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| Close Asset Management Ltd | 0 | $0 | 0.00% | −441−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −456−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −413−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −390−100.0% | Sold out |
| MPS Loria Financial Planners, LLC | 0 | $0 | 0.00% | −364−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −294−100.0% | Sold out |
| Grandview Asset Management LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Ellis Investment Partners, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Atlas Private Wealth Advisors | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Credit Agricole S A | 0 | $0 | 0.00% | −1−100.0% | Sold out |